【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Oncology – Market size and forecast 2018-2023
• Neurology – Market size and forecast 2018-2023
• Immunology – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Increasing awareness about therapeutic areas
• Presence of reimbursement and patient assistance programs
• Development of CD20 bispecific antibodies
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Amgen Inc.
• Celltrion Inc.
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Pfizer Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Product overview
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Product – Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Oncology – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Approved mABs for cancer indications
Exhibit 22: Oncology – Year-over-year growth 2019-2023 (%)
Exhibit 23: Neurology – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Neurology – Year-over-year growth 2019-2023 (%)
Exhibit 25: Immunology – Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Immunology – Year-over-year growth 2019-2023 (%)
Exhibit 27: Market opportunity by product
Exhibit 28: Customer landscape
Exhibit 29: Market share by geography 2018-2023 (%)
Exhibit 30: Geographic comparison
Exhibit 31: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Some of the approved anti-CD20 mABs in US
Exhibit 33: North America – Year-over-year growth 2019-2023 (%)
Exhibit 34: Top 3 countries in North America
Exhibit 35: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Some of the approved anti-CD20 mABs in Europe
Exhibit 37: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Europe
Exhibit 39: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 40: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in Asia
Exhibit 42: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 43: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 44: Top 3 countries in ROW
Exhibit 45: Key leading countries
Exhibit 46: Market opportunity
Exhibit 47: Some of the major combination therapies for anti-CD20 mABs
Exhibit 48: Serious side effects of anti-CD20 mABs
Exhibit 49: Effect on RITUXAN sales after the launch of biosimilars
Exhibit 50: Some of the recently approved rituximab biosimilars
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Some of the CD20 bispecific antibodies under development
Exhibit 53: Vendor landscape
Exhibit 54: Landscape disruption
Exhibit 55: Vendors covered
Exhibit 56: Vendor classification
Exhibit 57: Market positioning of vendors
Exhibit 58: Amgen Inc. – Vendor overview
Exhibit 59: Amgen Inc. – Organizational developments
Exhibit 60: Amgen Inc. – Geographic focus
Exhibit 61: Amgen Inc. – Key offerings
Exhibit 62: Amgen Inc. – Key customers
Exhibit 63: Celltrion Inc. – Vendor overview
Exhibit 64: Celltrion Inc. – Product segments
Exhibit 65: Celltrion Inc. – Organizational developments
Exhibit 66: Celltrion Inc. – Geographic focus
Exhibit 67: Celltrion Inc. – Segment focus
Exhibit 68: Celltrion Inc. – Key offerings
Exhibit 69: Celltrion Inc. – Key customers
Exhibit 70: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 71: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 72: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 73: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 74: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 75: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 76: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 77: Novartis AG – Vendor overview
Exhibit 78: Novartis AG – Business segments
Exhibit 79: Novartis AG – Organizational developments
Exhibit 80: Novartis AG – Geographic focus
Exhibit 81: Novartis AG – Segment focus
Exhibit 82: Novartis AG – Key offerings
Exhibit 83: Novartis AG – Key customers
Exhibit 84: Pfizer Inc. – Vendor overview
Exhibit 85: Pfizer Inc. – Business segments
Exhibit 86: Pfizer Inc. – Organizational developments
Exhibit 87: Pfizer Inc. – Geographic focus
Exhibit 88: Pfizer Inc. – Segment focus
Exhibit 89: Pfizer Inc. – Key offerings
Exhibit 90: Pfizer Inc. – Key customers
Exhibit 91: Validation techniques employed for market sizing
Exhibit 92: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル：抗CD20モノクローナル抗体（mAb）の世界市場2019-2023■ 英文：Anti-CD20 Monoclonal Antibodies (mABs) Market by Product and Geography - Global Forecast and Analysis 2019-2023
■ 発行日：2019年8月28日
■ 調査会社：Technavio
■ 商品コード：IRTNTR31859
■ 調査対象地域：グローバル、アジア太平洋、ヨーロッパ、北米、その他
- 産業自動化制御の世界市場：DCS、PLC、ドライブ、センサAbout the Industrial Automation Control Market Industrial automation control solutions help organizations to optimize business operations through efficient control of various processes with minimal (or reduced) human intervention. The data collected from field devices and systems gives businesses a competitive edge. Automation solutions such as DCS, PLC, drives, and sensors improve organizational …
- Network-as-a-Service（クラウド式ネットワークサービス）の世界市場予測（～2021年）“Infrastructure component adoption to play a significant role in augmenting the growth prospects in the Network-as-a-Service (NAAS) market”This study has been done on a global level, covering four regions broadly, : North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and & Latin America, and is projected to grow from USD 1.33 billion in 2016 to USD 9.65 billion by 2021, at a CA …
- PetroLatina Energy Limited：石油・ガスの開発・生産動向及びコスト分析- 2012PetroLatina Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary PetroLatina Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 生物除草剤の世界市場：微生物、生物化学品The market size for bioherbicides is projected to reach USD 1,573.7 Million by 2021, at a CAGR of around 14.5% from 2016. The global bioherbicides market has grown exponentially in the last few years. Asia-Pacifc countries such as China, Japan, and India are the primary targets of the industry. Increasing demand for organic products, reduced chemical hazards and easier residue management, improved …
- Roc Oil Company Limited：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Roc Oil Company Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Roc Oil Company Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
- WPX Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013WPX Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary WPX Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- ネットワーク管理ソフトウェアの世界市場2015-2019About Network Management Software Network management software manages computer networks that are spread over a wide range of network devices and software. The software is used to monitor, control, configure, troubleshoot, plan, allocate, deploy, and coordinate network-based business operations. This software also enables network managers to supervise the individual components within the network ma …
- 世界のリスク分析市場動向と予測：リスク計算エンジン、スコアボード、可視化、GRCThe risk analytics market analysis consists of various types of solution, service, application, verticals, and regions. The overall market size is found by adding up the market size of each solution and service such as consulting service, integration service and support and maintenance service. In risk analytics, each solution and service is playing an important role in the market. These solution …
- 疎水性塗料の世界市場予測（～2022年）“The hydrophobic coatings market is projected to register a CAGR of 5.5% between 2017 and 2022.”The market size of hydrophobic coatings is estimated to be 10,022.5 tons in 2017 and is projected to reach 13,099.0 tons by 2022, at a CAGR of 5.5% between 2017 and 2022. Increased demand for hydrophobic coatings from the automotive, aerospace, building & construction, marine, textiles, electronics and …
- 締固め機械の世界市場2017-2021About Compaction EquipmentA compactor is a machine or mechanism used to reduce the thickness of materials such as soil, aggregates, concrete, and so on by filling the air voids present in the material. Technavio’s analysts forecast the global Compaction Equipment market to grow at a CAGR of 4.74% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the g …
- Epidermolysis Bullosa：グローバル臨床試験レビューH2, 2013Epidermolysis Bullosa Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, H2, 2013" provides data on the Epidermolysis Bullosa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Epidermolysis Bullosa. It includes an overview of the trial numbers and the …
- たばこ製造・販売企業分析：Gudang GaramSynopsis This report provides a unique and comprehensive analysis of the company Global, Regional and National Tobacco Players: Gudang Garam, including the corporate profile, organisation structure, financial data, and competitive positioning. The analysis also details the organisation's history, merger and acquisition activity, licensing agreements, brand portfolio, as well as an assessment of co …
- 組み込みソフトウェアの世界市場2017-2021ABSTRACTAbout Embedded Software Embedded software is a computer program or code running on hardware, guiding and controlling the actions of the device. It acts as an interface between underlying hardware and end-users. It is built into hardware systems, written on computer chips, and applied in real-time systems such as ATMs, missiles, and airplanes. Examples of embedded software in our daily life …
- 伝染性下痢(Infectious Diarrhea)：世界の治験レビュー（2015年上半期版）Infectious Diarrhea Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Infectious Diarrhea Global Clinical Trials Review, H1, 2015" provides data on the Infectitious Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Infectitious Diarrhea . It includes an overview of the trial numbers and their …
- デジタルセキュリティソリューションの世界市場：脅威インテリジェンス・アナリティクス、エンドポイントセキュリティ、コンテンツセキュリティゲートウェイ、クラウドセキュリティ、Eメール暗号化、M2MネットワークセキュリティAbout Digital Security Digital security solutions are gaining importance among large enterprises, government organizations, and SMBs because they protect critical information from unauthorized access and security attacks. They also protect computers and digital devices from malware, worms, and advanced security threats. Digital security has been gaining prominence over the years because of the inc …
